Weili Zhao

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

• Epstein-Barr virus-positive diffuse large B-cell lymphoma→
• Aggressive B-cell non-Hodgkin lymphoma→
• B-cell chronic lymphocytic leukemia→
• Follicular lymphoma→
• Diffuse large B-cell lymphoma→
• Extranodal nasal NK/T cell lymphoma→
• Angioimmunoblastic T-cell lymphoma→

Clinical trials (16)

• NCT05192486
• NCT05899621
• NCT03853044
• NCT05923502
• NCT06093841
• NCT04705129
• NCT02631239
• NCT05365100
• NCT04231448
• NCT05234684
• NCT06725524
• NCT04480125
• NCT04880746
• NCT06601504
• NCT07409428
• NCT04812691

Verify independently

• ClinicalTrials.gov PI search for Weili Zhao

Other specialists for Epstein-Barr virus-positive diffuse large B-cell lymphoma

Peers ranked by clinical-trial PI role, publications, and verification quality.

• Kurt Gunter, MD, M.D
  Inozyme Pharma, Inc.
  MA
• Ajay Gopal
  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
  WA
• Colleen Delaney, MD
  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
  CT
• Jennifer Crombie, MD, M.D
  Dana-Farber Cancer Institute
  MA
• Nancy Wells, DNSc, RN
  Vanderbilt-Ingram Cancer Center
• Philip L. McCarthy, MD
  Roswell Park Cancer Institute
• Paul Martin
  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
• Karen Syrjala
  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
  WA

See all specialists for Epstein-Barr virus-positive diffuse large B-cell lymphoma →